• Catabasis Pharmaceuticals, Inc. Bumps Series A to $47.6 Million More...

• ImmusanT, Inc. Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease More...

• Federal Trade Commission Orders Valeant Pharmaceuticals International (VRX) to Sell 3 Drugs to Acquire Dermatology Businesses More...

• Jazz Pharmaceuticals, Inc. (JAZZ) Announces Stockholder Vote in Favor of Transaction With Azur Pharma Inc. More...

• Valeant Pharmaceuticals International (VRX) Announces the Completion of the Privatization of Afexa Life Sciences Inc. More...

• Baxter International, Inc. (BAX) Signs Definitive Agreement to Acquire Synovis Life Technologies, Inc. (SYNO) More...

• Liquidia Technologies Inc. Announces Collaboration with PATH to Develop Next Generation Pneumococcal Vaccine More...

• Intarcia Therapeutics, Inc. and Quintiles, Inc. (QTRN) Finalize Innovative Alliance to Advance Global Phase 3 Program for ITCA 650 in Type 2 Diabetes More...

• BioLineRx Ltd. to Develop and Commercialize Novel Peptide Drug Candidates Discovered by Compugen Ltd. (CGEN) More...

• Cellceutix (CTIX) Provides Updates on IND for Cancer Drug, Initiates Collaborative Agreement With Pioneer Valley Life Sciences Institute (PVLSI) for Mitochondrial Research More...

• IntelliCell BioSciences (SVFC) Announces Powerful Collaboration with Numoda Corporation More...

• Pfizer Inc. (PFE) Names Read Chairman, OKs $10 Billion in Buybacks More...

• GenVec Inc. (GNVC) President and Chief Executive Officer Announces Retirement More...

• Advanced BioScience Laboratories, Inc. Announces Hiring of Bioprocessing Specialist to GMP Manufacturing Team More...

• Essentialis Appoints Richard C. Pasternack, MD, to its Board of Directors More...

• Amarantus BioSciences, Inc. Appoints Mark J. Benedyk, PhD as Strategic Advisor More...

• AVANIR Pharmaceuticals (AVNR) Reports Fiscal 2011 Fourth Quarter and Year End Financial Results More...

• Enzo Biochem (ENZ) Reports Fiscal First Quarter 2012 Results More...

• Peregrine Pharmaceuticals, Inc. (PPHM) Reports Second Quarter 2012 Financial Results and Recent Developments More...

• SEC Charges GlaxoSmithKline (GSK)'s Stiefel Laboratories and Its Ex-CEO of Fraud More...

• Synergy Pharmaceuticals Files Suit Against Ironwood Pharmaceuticals and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie More...

• Warner Chilcott, PLC (WCRX) Announces Decision on Appeal of DORYX Preliminary Injunction More...
• Novartis AG (NVS): Patient Died After Starting Gilenya More...

• Lannett Company, Inc. (LCI) Receives FDA Approval for Triamterene with Hydrochlorothiazide 37.5/25mg Capsules More...

• Alexza Pharmaceuticals, Inc. (ALXA) Surges After FDA Panel Backs Inhaled Antipsychotic Drug More...

• Eisai Company, Ltd. (ESALY.PK) Submits Application in Japan for New Dry Syrup Formulation of its Alzheimer's Disease Treatment Aricept More...

• Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA(TM) Oral Calcitonin More...

• Results From Gentium S.p.A.'s Treatment IND for Defibrotide Presented at theAmerican Society of Hematology Annual Meeting More...

• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drug Cuts Myeloma Death Risk in 5-Year Study More...
• Anacor Pharmaceuticals, Inc. Announces Positive Preliminary Results from Phase 2a Trial of AN2728 and AN2898 in Atopic Dermatitis More...

• Symphogen A/S Presents Positive Rozrolimupab (SYM001) Phase 2 Trial Results in ITP at American Society of Hematology More...

• Cell Therapeutics, Inc. (CTIC) and Chroma Therapeutics Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML) More...

• Top-Line Phase 2 Data Indicate Repros Therapeutics Inc. (RPRX)'s Androxal(R) Normalizes Testicular Function in Men With Type 2 Diabetes More

• ADHD Drugs Don't Raise Risk of Heart Problems, Kaiser Permanente Study More...

• Blink Patterns May be a Window into Autistic Mind, Emory University School of Medicine Study More...

• Friends and Loved Ones Yawn Together, University of Pisa Study More...

• Cancer Outpatients at Greater Risk for Blood Clots, University of Rochester Medical Center Study More...

• People With DFNA2 Hearing Loss Show Increased Touch Sensitivity, Max Delbruck Center Study More...